IGC
Price
$0.31
Change
+$0.02 (+6.90%)
Updated
Apr 24 closing price
Capitalization
25.01M
54 days until earnings call
VTGN
Price
$2.34
Change
+$0.16 (+7.34%)
Updated
Apr 24 closing price
Capitalization
67.54M
Ad is loading...

IGC vs VTGN

Header iconIGC vs VTGN Comparison
Open Charts IGC vs VTGNBanner chart's image
IGC Pharma
Price$0.31
Change+$0.02 (+6.90%)
Volume$941.43K
Capitalization25.01M
VistaGen Therapeutics
Price$2.34
Change+$0.16 (+7.34%)
Volume$134.72K
Capitalization67.54M
IGC vs VTGN Comparison Chart
Loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGC vs. VTGN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGC is a StrongBuy and VTGN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (IGC: $0.31 vs. VTGN: $2.34)
Brand notoriety: IGC and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGC: 281% vs. VTGN: 97%
Market capitalization -- IGC: $25.01M vs. VTGN: $67.54M
IGC [@Biotechnology] is valued at $25.01M. VTGN’s [@Biotechnology] market capitalization is $67.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGC’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • IGC’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than IGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGC’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 6 bullish TA indicator(s).

  • IGC’s TA Score: 5 bullish, 5 bearish.
  • VTGN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than IGC.

Price Growth

IGC (@Biotechnology) experienced а +10.61% price change this week, while VTGN (@Biotechnology) price change was +10.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

IGC is expected to report earnings on Aug 08, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($67.5M) has a higher market cap than IGC($25M). IGC YTD gains are higher at: -6.607 vs. VTGN (-20.678). IGC has higher annual earnings (EBITDA): -7.58M vs. VTGN (-52.22M). VTGN has more cash in the bank: 88.6M vs. IGC (470K). IGC has less debt than VTGN: IGC (270K) vs VTGN (1.71M). IGC has higher revenues than VTGN: IGC (1.24M) vs VTGN (698K).
IGCVTGNIGC / VTGN
Capitalization25M67.5M37%
EBITDA-7.58M-52.22M15%
Gain YTD-6.607-20.67832%
P/E RatioN/AN/A-
Revenue1.24M698K177%
Total Cash470K88.6M1%
Total Debt270K1.71M16%
FUNDAMENTALS RATINGS
IGC vs VTGN: Fundamental Ratings
IGC
VTGN
OUTLOOK RATING
1..100
2254
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
7890
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (46) in the Biotechnology industry is in the same range as IGC (51). This means that VTGN’s stock grew similarly to IGC’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IGC (100). This means that VTGN’s stock grew similarly to IGC’s over the last 12 months.

VTGN's SMR Rating (94) in the Biotechnology industry is in the same range as IGC (96). This means that VTGN’s stock grew similarly to IGC’s over the last 12 months.

IGC's Price Growth Rating (78) in the Biotechnology industry is in the same range as VTGN (90). This means that IGC’s stock grew similarly to VTGN’s over the last 12 months.

IGC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VTGN (100). This means that IGC’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IGCVTGN
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSLY5.850.35
+6.36%
Fastly
PSN67.332.26
+3.47%
Parsons Corp
AROW25.200.20
+0.82%
Arrow Financial Corp
DHR196.500.19
+0.10%
Danaher Corp
CABA1.27-0.07
-5.22%
Cabaletta Bio

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
+6.73%
TECX - IGC
39%
Loosely correlated
+14.53%
ANVS - IGC
30%
Poorly correlated
+8.61%
AMLX - IGC
30%
Poorly correlated
+3.56%
LRMR - IGC
29%
Poorly correlated
+4.87%
VTGN - IGC
27%
Poorly correlated
+7.34%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ABOS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+7.34%
ABOS - VTGN
44%
Loosely correlated
+7.84%
ATAI - VTGN
42%
Loosely correlated
+0.66%
KYMR - VTGN
42%
Loosely correlated
+9.32%
ZYME - VTGN
40%
Loosely correlated
+0.56%
SRRK - VTGN
40%
Loosely correlated
+5.72%
More